➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
Boehringer Ingelheim

Last Updated: October 24, 2021

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for dapsone

Email this page to a colleague

« Back to Dashboard

Bulk Pharmaceutical API Sources for dapsone

Vendor Vendor Homepage Vendor Sku API Url
ChemExper Chemical Directory ⤷  Free Forever Trial jhiPb@OA``@QddabbRRvRkF\m@@@E@@@ ⤷  Free Forever Trial
ChemBridge ⤷  Free Forever Trial 5128048 ⤷  Free Forever Trial
Sigma-Aldrich ⤷  Free Forever Trial A74807_ALDRICH ⤷  Free Forever Trial
Hangzhou Trylead Chemical Technology ⤷  Free Forever Trial TL8005401 ⤷  Free Forever Trial
MP Biomedicals ⤷  Free Forever Trial 212644 ⤷  Free Forever Trial
NovoSeek ⤷  Free Forever Trial 2955 ⤷  Free Forever Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.